After years of stagnation, Gilead is betting that a twice-yearly HIV shot can restart its growth engine.

After seeing an exhibition of ACT-UP buttons, a reader wrote to What’s Your KCQ for more information about the organization’s ...

By bolstering immune cells, researchers at ViiV Healthcare in Branford have designed long-acting drugs that prevent infection ...

FA new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration (FDA) later this month.

A UVa researcher has discovered that NRTIs, drugs used to treat HIV, can also help prevent Alzheimer's and a long list of ...

The Trump administration has moved to end funding for a broad swath of HIV vaccine research, saying current approaches are ...

The current administration has pulled millions in HIV-related grants and cut staffing positions essential to research and ...

Gilead's twice-yearly HIV injection faces headwinds from US aid pullback. Gilead Sciences says it still plans to supply its ...

Of 49 countries surveyed in a recent analysis, 15 have historically relied on the the U.S. for most of the funding for their ...

A group of women in Kenya rebelled against trading sex for a fisherman's catch to sell. They got their own boats, had success ...